Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, China.
Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, China.
J Cardiol. 2020 Sep;76(3):309-316. doi: 10.1016/j.jjcc.2020.03.008. Epub 2020 Apr 27.
Although technological and equipment innovations have given rise to delicate and safe coronary intervention procedures, periprocedural myocardial injury (PMI) is still one of the common complications. The relationship between PMI, defined by various biomarker thresholds, and clinical prognosis remains controversial. We sought to assess the determinants and prognosis of PMI in patients with stable coronary artery disease (CAD) undergoing elective percutaneous coronary intervention (PCI).
Consecutive stable CAD patients with negative preoperative troponin T levels undergoing elective PCI in our hospital were enrolled from July 2017 to December 2017. PMI was defined as troponin T values >99th percentile upper reference limit (URL) within 16-24h post-PCI. The correlation of cardiovascular events and PMI was assessed after a median follow-up of 18 months.
PMI occurred in 45.3% of the 1572 patients included, with 11.2% having troponin T levels elevated more than 5 times the URL after PCI. Independent risk factors for PMI were age ≥65 years, prior PCI, bifurcation lesion, stent number, and multivessel disease. During the follow-up period, patients with PMI had a higher incidence of unplanned revascularization [10.8% vs. 7.2%, adjusted hazard ratio (adHR) 1.40, 95% confidence interval (CI) 1.04-2.06; p=0.045] and target vessel revascularization (5.8% vs. 2.7%, adHR 1.90, 95% CI 1.06-3.38; p=0.030) than those without PMI. However, no significant impact of PMI on the risk of death and myocardial infarction was found.
PMI defined by troponin T levels >99th percentile URL correlated with an increased risk of cardiovascular events in stable CAD patients undergoing elective PCI.
尽管技术和设备创新带来了精细和安全的冠状动脉介入治疗程序,但围手术期心肌损伤(PMI)仍然是常见的并发症之一。各种生物标志物阈值定义的 PMI 与临床预后之间的关系仍存在争议。我们旨在评估稳定型冠状动脉疾病(CAD)患者行选择性经皮冠状动脉介入治疗(PCI)时 PMI 的决定因素和预后。
连续纳入 2017 年 7 月至 2017 年 12 月在我院行选择性 PCI 的术前肌钙蛋白 T 水平阴性的稳定型 CAD 患者。PMI 定义为 PCI 后 16-24 小时内肌钙蛋白 T 值>99 百分位上参考限(URL)。在中位随访 18 个月后评估心血管事件与 PMI 的相关性。
1572 例患者中 45.3%发生 PMI,其中 11.2%的患者 PCI 后肌钙蛋白 T 水平升高超过 URL 的 5 倍。PMI 的独立危险因素为年龄≥65 岁、既往 PCI、分叉病变、支架数量和多血管病变。随访期间,PMI 患者计划外血运重建发生率较高[10.8%比 7.2%,调整后的危险比(adHR)1.40,95%置信区间(CI)1.04-2.06;p=0.045]和靶血管血运重建(5.8%比 2.7%,adHR 1.90,95%CI 1.06-3.38;p=0.030)高于无 PMI 患者。然而,PMI 对死亡和心肌梗死风险无显著影响。
以肌钙蛋白 T 水平>99 百分位 URL 定义的 PMI 与稳定型 CAD 患者行选择性 PCI 后心血管事件风险增加相关。